Trending...
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Cent Capital Launches FinPedia, a Free Financial Literacy Resource for Personal Finance and Investing
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
IRVINE, Calif. and LONDON, July 22, 2024 ~ London, UK - Medical and Commercial International Limited (MCI), a leading specialized liability underwriting company, has joined forces with GATC Health Corp, a technology company utilizing artificial intelligence in drug discovery, to launch a groundbreaking program that will revolutionize the financing of clinical trials. This first-of-its-kind initiative, approved by Lloyd's of London, will provide insurance coverage for biotech companies in the event of trial failure.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
- OhMyPretty Burmese Curly Bundles Redefine Long-Lasting, Chic, Versatile Curls
- New Book Call all Jews to Accept Jesus as the Messiah
- Flux AI Launches CRAISEE — The World's First All-in-One Generative AI Platform
- Governor Newsom pre-deploys additional storm safety resources to Southern California ahead of extreme weather
- 10xDev Launches in Los Angeles
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
- City of Long Beach Preparing for Upcoming Weather Event, Urges Residents to Take Precautions
- Jimmy Swinder Launches "Jimmy Swinder Productions," Expanding Creative Reach
- Industrial CNC Machinery automates machining processes with high accuracy and reduced labor costs
- For Nat'l. Novel Writing Month: Check out The Next Big Thing in Entertainment for Books, Movies & TV
- MetroWest wellness: Holliston farmhouse spa unveils Centerpoint Studio
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
Filed Under: Business
0 Comments
Latest on The Californer
- Viewing Figures: Soap Opera Insights and Viewership
- Destination: Scientology, Del Valle Celebrates the Cultural Heritage of Mexico
- Jaipur Countryside, 4-Star Comfort: $199 for Two— All-Inclusive with Meals + Transfers at Heritage Hotel Savista
- The Underdog Rises: The First Lady Olivia and Tanasha Donna
- California: Governor Newsom signs bill to protect parents' rights and children
- Probate Shepherd® Announces a New Member Probate Attorney in Fort Worth, TX
- Phinge Announces "Test the Waters" Campaign for Potential Regulation A+ Offering: Home of Netverse Verified AI & Patented App-less Technology Platform
- Why Jobseekers Should Invest in a Professional Resume Writer
- Voices for Humanity Leads Resurgence of Moral Values in Hungary with Antónia and Ferenc Novák
- Richline Transportation Elevates San Diego Airport Transfers with Luxury Black Car Service
- RJ Grimshaw Launches "The AI EDGE" A Practical Guide Where Leadership Meets Innovation
- WECS TV Show San Francisco ~ Dallas Spotlights Sherri Young, AASC Executive Director
- California: Governor Newsom statement on the passing of Diane Keaton
- California: Governor Newsom issues legislative update 10.11.25
- Probate Shepherd® Announces a New Member Probate Attorney in Sugar Land, TX
- California: Governor Newsom signs SB 41 to lower the cost of prescription drugs
- New Song "Soccer Will Soar" Celebrates Upcoming 2026 World Cup and Welcomes Fans to the USA
- New Sports Card Addition to The Shoppes at Carlsbad
- Governor Newsom signs legislative package to expand services and resources for Californian women
- Live Good Leads with Love: Creating Opportunity, Protecting the Vulnerable and Inspiring Hope